GZTC Message Board - Msg: 6037997

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZTC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Barbara Bullard who wrote ()	10/16/1998 2:12:00 AM
From: HIA	Read Replies (1) of 752

I see this company as a small-cap that could become a mid-cap within five years or so...The key factor is a product that could reduce the amount of plasma used in by-pass surgery...and so this product is likely to become a well known commercial product...But there are several other promising developments...and the advantage to this technology is the large amounts that can be produced...I'll list the three or four other products likely to become commercial products in another post... So here is a small-cap bio-tech that has $50 million in annual revenue...and a commercial product in phase III development...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next